1.
Inflammation in Alzheimer disease: driving force, bystander or beneficial response?
by Wyss-Coray, Tony
Nature medicine, 2006-09, Vol.12 (9), p.1005-1015
2.
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
by Ramiro, Sofia
Annals of the rheumatic diseases, 2014-08, Vol.73 (8), p.1455-1461
3.
Amelioration of FCA induced arthritis on topical application of curcumin in combination with emu oil
by Jeengar, Manish Kumar, M.S. (Pharm.)
Nutrition (Burbank, Los Angeles County, Calif.), 2016, Vol.32 (9), p.955-964
4.
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs
by NUGENT, S G
Gut, 2001-04, Vol.48 (4), p.571-155
5.
Nanosilver as a new generation of nanoproduct in biomedical applications
by Chaloupka, Karla
Trends in biotechnology (Regular ed.), 2010, Vol.28 (11), p.580-588
6.
Pericardial involvement in systemic inflammatory diseases
by Imazio, Massimo
Heart, 2011-11, Vol.97 (22), p.1882-1892
7.
Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
by Mazor, Y.
Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.620-628
8.
Inflammatory Bowel Disease: Perioperative Pharmacological Considerations
by Kumar, Ajay, MD, MRCP
Mayo Clinic proceedings, 2011, Vol.86 (8), p.748-757
9.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
by Bhattacharya, Palash
Journal of interferon & cytokine research, 2015-08-01, Vol.35 (8), p.585-599
10.
Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D
by KRISHNAN, Aruna V
Annual review of pharmacology and toxicology, 2011, Vol.51 (1), p.311-336
11.
The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study
by Avunduk, Avni Murat
American journal of ophthalmology, 2003, Vol.136 (4), p.593-602
12.
Meta‐analysis: the efficacy of rectal beclomethasone dipropionate vs. 5‐aminosalicylic acid in mild to moderate distal ulcerative colitis
by MANGUSO, F.
Alimentary pharmacology & therapeutics, 2007-07, Vol.26 (1), p.21-29
13.
Selenium in Human Health and Disease
by Fairweather-Tait, Susan J.
Antioxidants & redox signaling, 2011-04-01, Vol.14 (7), p.1337-1383
14.
Episcleritis and scleritis: clinical features and treatment results
by Jabs, Douglas A
American journal of ophthalmology, 2000, Vol.130 (4), p.469-476
15.
Therapy of Steroid-Resistant Inflammatory Bowel Disease
by Manz, Michael
Digestion, 2012-10, Vol.86 (1), p.11-15
16.
Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study
by Gül, Ahmet
Annals of the Rheumatic Diseases, 2012-04, Vol.71 (4), p.563-566
17.
Butein in health and disease: A comprehensive review
by Padmavathi, Ganesan
Phytomedicine (Stuttgart), 2017-02-15, Vol.25, p.118-127
18.
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
by Soo, Y.O.Y
Clinical microbiology and infection, 2004-07, Vol.10 (7), p.676-678
19.
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
by Andréjak, Claire
Thorax, 2013-03, Vol.68 (3), p.256-262
20.
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis
by Miehlke, Stephan Stephan
Gut, 2015-03-19, Vol.65 (3), p.390-399
